ZJ23F1001473
Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Inebilizumab (anti-CD19) - Primary antibody, specific to CD19, >95%, high purity, Human IgG1, BINDING AGENT of B-lymphocyte antigen CD19 binding agent, BINDING AGENT of B-lymphocyte antigen CD19 binding agent
- Host species: Human
- Reactive species: Human,Mouse
- Isotype: Human IgG1
- Conjugation: Unconjugated
In stock
Item Number
Ab170867
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab170867-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$49.90
|
|
|
Ab170867-1mg
|
1mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$229.90
|
|
|
Ab170867-5mg
|
5mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$589.90
|
|
|
Ab170867-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$949.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated